Jubilant Generics Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24100UP2013FLC060821 Incorporated 25 November 2013 ROC Uttar Pradesh HQ Noida, Uttar Pradesh, India
Active Public Limited Foreign Company Incorporated In India pharma
Data last updated
Revenue · FY 2023
₹326.62 Cr
▼ 75% YoY
Net loss · FY 2023
₹188.76 Cr
Net margin -57.8%
EBITDA · FY 2023
-₹103.3 Cr
EBITDA margin -31.6%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.58 Cr
Issued & subscribed
Open charges
₹500 Cr
Satisfied ₹810 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
1,106
Provident fund records

About Jubilant Generics Limited

Data last updated:

Jubilant Generics Limited is a public limited foreign company incorporated in india based in Noida, Uttar Pradesh, India, a subsidiary of Jubilant Pharmova Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 November 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2013FLC060821. Its GSTIN is 09AADCJ2401L1ZO (Uttar Pradesh). The company holds 12 GST registrations, all of them active.

The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.58 Cr. It is led by directors including Jaidev Sanjeev Rajpal (Managing Director) and Gayatri Taragi.

Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 1A Sector 16A Institutional Area Noida, Uttar Pradesh, India – 201301.

As per the financials filed for FY 2023, the company reported a revenue of ₹326.62 Cr, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹188.76 Cr (net margin -57.8%) and EBITDA of -₹103.3 Cr (EBITDA margin -31.6%). Revenue has declined at a compounded annual rate (CAGR) of 35% over three years and 20% over five years.

The company has about 1,106 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Jubilant Generics. As per MCA filings, the company has open charges of ₹500 Cr and satisfied charges of ₹810 Cr on record. Court records list 25 cases involving the company, including 9 filed by the company and 16 filed against it; 9 cases are pending. The company has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016. The company has 3 MSME Form 1 returns on record between 2022 and 2023, listing 692 overdue payments to 165 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jubilantgenerics.com.

Company details

CIN U24100UP2013FLC060821
Registration Number 060821
Incorporation Date 25 November 2013
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Jubilant Pharmova Limited
Compliance Status Active Compliant

Contact details

Jubilant Generics Limited's registered office is in Noida, Uttar Pradesh. Its website is jubilantgenerics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot 1A Sector 16A Institutional Area Noida, Uttar Pradesh, India – 201301
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Jubilant Generics Limited, buy the company report.

Comprehensive company report
Jubilant Generics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Jubilant Generics operates one associated brand: Jubilant Generics. Each brand links to its own profile.

BrandDescriptionWebsite
Focuses on R&D and manufacturing of drugs for various therapeutic areas.jubilantgenerics.com

Financials of Jubilant Generics Limited

FY 2025 filings available

Jubilant Generics Limited reported revenue of ₹326.62 Cr (down 75% YoY) for FY 2023.

Revenue · FY 2023
₹326.62 Cr ▼ 75%
Net loss · FY 2023
₹188.76 Cr margin -57.8%
EBITDA · FY 2023
-₹103.3 Cr margin -31.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 75%
3 years · compounded
▼ 35%
5 years · compounded
▼ 20%

Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 75% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹326.62 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹103.3 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹188.76 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-31.6%
Net Profit Margin-57.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jubilant Generics Limited, buy the company report.

Board of directors of Jubilant Generics Limited

Jubilant Generics has 3 current directors and 22 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gayatri TaragiDirector21 May 20242 Years 5 MonthsCurrent
Jaidev Sanjeev RajpalManaging Director11 Oct 20224 Years 0 MonthsCurrent
Shirish Gundopant BelapureDirector20 Jun 20242 Years 4 MonthsCurrent

Auditor

Jubilant Generics Limited is audited by B S R & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2023101248W/W-100022

Shareholding

The shareholding of Jubilant Generics Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jubilant Generics Limited, buy the company report.

Charges & borrowings

Open charges
₹500 Cr
Satisfied charges
₹810 Cr
Breakdown by lending institutions
Others₹500.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Jan 201510542119Others₹500 CrOpen
05 Feb 201610622549Indusind Bank Ltd.₹100 CrSatisfied
30 Sep 201410532814Il & Fs Trust Company Limited₹130 CrSatisfied
23 Sep 201410522898Export Import Bank of India₹30 CrSatisfied
30 Jul 201410514981The Ratnakar Bank Limited₹50 CrSatisfied

To see the full charge records of Jubilant Generics Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Jubilant Generics Limited has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016.

Total deals
4
Funding rounds
2
Convertible or debt financings
2
Disclosed funding
₹2,078.07 Cr

To see the full deal history of Jubilant Generics Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Jubilant Generics Limited was last rated by Indiarating on 18 Feb 2022.

Rating agencyRated onRating
Indiarating18 Feb 2022

To see the full credit ratings and regulatory alerts of Jubilant Generics Limited, buy the company report.

MSME payment delays

Jubilant Generics Limited has 3 MSME Form 1 returns on record between 2022 and 2023, listing 692 overdue payments to 165 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 165)

SupplierAmount dueDue sinceReported on
Benchmark Esg Private Limited
an individual supplier
an individual supplier
an individual supplier
Glatt (India) Engineering Private Limited

To see the full MSME payment records of Jubilant Generics Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Jubilant Generics Limited has a workforce of 1,106 employees on its EPFO records as of Apr 06, 2024, across 3 active EPFO establishments.

Employee count
1,106
Active EPFO establishments
3
Employee growth
-31.26%

GST

Jubilant Generics has 12 GST registrations: 12 active. The first 4 active GSTINs are listed below.

Total GSTINs
12
Active
12
GSTINStateStatusRegistered on
09AADCJ2401L1ZOUttar PradeshActive01 Jul 2017
09AADCJ2401L7ZIUttar PradeshActive13 Jul 2017
05AADCJ2401L1ZWUttarakhandActive01 Jul 2017
29AADCJ2401L1ZMKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Jubilant Generics Limited, buy the company report.

Recent activity

Jubilant Generics Limited has 26 board changes on record since 2015: 5 appointments and 21 cessations. The latest: Gayatri Taragi ceased to be Additional Director on 29 Sep 2024.

AGM
Jubilant Generics Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records.
Filing
Jubilant Generics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Ceased
Gayatri Taragi ceased to be Additional Director.
Ceased
Shirish Gundopant Belapure ceased to be Additional Director.
Appointed
Shirish Gundopant Belapure was appointed as Director.
Appointed
Gayatri Taragi was appointed as Director.
Appointed
Jaidev Sanjeev Rajpal was appointed as Managing Director.
Ceased
Jaidev Sanjeev Rajpal ceased to be Additional Director.
Ceased
Ramamurthi Kumar ceased to be Additional Director.
Ceased
Anant Pande ceased to be Director.
Ceased
Arvind Chokhany ceased to be Additional Director.
Ceased
Christopher Stanley Krawtschuk ceased to be Additional Director.

35 earlier events are in the company report.

Frequently asked questions

Jubilant Generics is an active public limited foreign company incorporated in india based in Noida, Uttar Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 November 2013 (13+ years old) and is registered under CIN U24100UP2013FLC060821.

Jubilant Generics has 3 current directors:

The latest financial statements of Jubilant Generics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Jubilant Generics is 09AADCJ2401L1ZO, registered in Uttar Pradesh. The company has 12 GST registrations in all, of which 12 are active. Other active GSTINs include 09AADCJ2401L7ZI (Uttar Pradesh), 05AADCJ2401L1ZW (Uttarakhand), 29AADCJ2401L1ZM (Karnataka).

The CIN (Corporate Identification Number) of Jubilant Generics is U24100UP2013FLC060821. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jubilant Generics has 25 court cases on record: 9 filed by the company and 16 filed against it. 9 are pending. Most are in the high courts.

Jubilant Generics was incorporated on 25 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Jubilant Generics has 4 deals on record (2 funding rounds, 2 convertible or debt financings), with disclosed funding of ₹2,078.07 Cr; the latest was in October 2016.

Gayatri Taragi ceased to be Additional Director on 29 Sep 2024. Shirish Gundopant Belapure ceased to be Additional Director on 29 Sep 2024. Shirish Gundopant Belapure was appointed as Director on 20 Jun 2024. Jubilant Generics has 26 board changes on record in total.

Jubilant Generics has 3 MSME Form 1 returns on record between 2022 and 2023, listing 692 overdue payments to 165 micro and small suppliers. The latest return was filed on 31 Aug 2023.

Jubilant Generics can be reached through the website jubilantgenerics.com. Its registered office is in Noida, Uttar Pradesh, India.